The amino-bisphosphonates are first-line therapy for the treatment of most patients with
osteoporosis, with proven efficacy to reduce fracture risk at the spine, hip, and other …

Purpose: To review what is known about the adverse effects on the cornea from various
classes of medications. New data from previously unreported cases of drug-related corneal …

PURPOSE: To report recent ocular adverse drug reactions identified by the National
Registry of Drug-Induced Ocular Side Effects. METHODS: Case reports from the National …

Resumen La Asociación Colombiana de Osteoporosis y Metabolismo Mineral se reunió a
principios de 2017 para actualizar el Consenso Colombiano de Osteoporosis, elaborado …

The ever-broadening scope of pharmaceuticals now available to treat previously untreatable
conditions, such as advanced metastatic cutaneous melanoma, have resulted in unintended …

Purpose: Uveitis and scleritis are the most serious ocular side effects of bisphosphonate
therapy. The purpose of this study was to determine the 6-month rates of uveitis/scleritis …

Nearly every drug may cause changes to ocular tissues through a variety of mechanisms.
Medication overdoses, drug—drug interactions but also chronic administration of …

Background Several studies have suggested that Langerhans cell histiocytosis (LCH) is
responsive to treatment with bisphosphonates (BPs). However the efficacy and safety of BPs …

Drug-induced uveitis has become increasingly recognized in association with a number of
commonly used systemic, intraocular, and topical medications. A detailed history is often all …

Discussion Cases of ocular inflammation in patients taking bisphosphonates have been
reported since the early 1990s. 5, 6 Cases have involved both nitrogen and non-nitrogen …